Omnicell, Inc. (OMCL) — Stock Score Summary

Omnicell, Inc. (OMCL) has a MoatMap StockRank of 72/100 based on Quality (55/100), Value (39/100), and Momentum (62/100) factor scores. The current signal is BUY. Omnicell provides automated medication management systems. The company is currently undergoing a complex operational turnaround amid tight hospital capital expenditure budgets. This does not meet our strict requirement for high-ROIC quality compounders with immediate macro tailwinds.

Omnicell, Inc. is a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies globally. The company offers automated dispensing systems, medication adherence packaging, and analytics software, enhancing efficiency and patient safety in medication workflows. Omnicell's integrated platform and advanced automation technology create a significant competitive advantage in the healthcare IT and pharmacy automation market.

Key Financial Metrics

Price$40.69
Market Cap$2.0B
P/E (TTM)99.09
P/E (Forward)19.86
Price/Book1.59
Return on Equity1.6%
Return on Invested Capital0.3%
Debt/Equity16.09
Gross Margin43.9%
Operating Margin5.4%
Revenue Growth14.9%
Free Cash Flow$113M

Omnicell, Inc. operates in the Health Information Services industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Omnicell, Inc.’s (OMCL) StockRank?
MoatMap’s StockRank for Omnicell, Inc. (OMCL) is 72/100, with a Buy signal. It is a composite of Quality (55), Value (39), and Momentum (62) factor ranks across MoatMap’s 19,000+ stock universe.
Does Omnicell, Inc. have an economic moat?
Omnicell, Inc. (OMCL) has a Quality factor score of 55/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Omnicell, Inc. a buy, hold, or sell?
MoatMap’s current signal for Omnicell, Inc. (OMCL) is Buy, based on a StockRank of 72/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Omnicell, Inc. in?
Omnicell, Inc. (OMCL) operates in the Healthcare sector, specifically the Health Information Services industry (United States).
Browse all ranked stocksOMCL deep dive reportAI ChampionsHow we score stocksSense-check another stock